miR-155 in the progression of lung fibrosis in systemic sclerosis
2016 · Arthritis Research & Therapy · 104 citations
https://doi.org/10.1186/s13075-016-1054-6
D
Daniel J. Kass
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
190
Papers
4.8K
Citations
37
h-index
68
i10-index
Daniel J. Kass is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Chronic Obstructive Pulmonary Disease (COPD) Research & Pulmonary Hypertension Research and Treatments. The author has an h-index of 37, co-authored 162 publications.
ORCID: 0000-0001-6597-7830Papers by this author
worksAssociation of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung Disease
2022 · JAMA Internal Medicine · 104 citations
https://doi.org/10.1001/jamainternmed.2022.4696
Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease – analysis of institutional and population data
2018 · Respiratory Research · 79 citations
https://doi.org/10.1186/s12931-018-0899-4
VCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis
2015 · Cellular Signalling · 76 citations
https://doi.org/10.1016/j.cellsig.2015.09.003
Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis
2016 · Scientific Reports · 46 citations
https://doi.org/10.1038/srep33116
Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle
2020 · American Journal of Respiratory Cell and Molecular Biology · 44 citations
https://doi.org/10.1165/rcmb.2020-0470tr
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat